Literature DB >> 1892589

HIV prevalence and risk behaviours for HIV transmission in South Australian prisons.

M D Gaughwin1, R M Douglas, C Liew, L Davies, A Mylvaganam, H Treffke, J Edwards, R Ali.   

Abstract

During the latter half of 1989, HIV prevalence in South Australian prisoners was 1.4%. The prevalence of HIV infection across the prison system did not change significantly during 1989 but there was clustering of HIV-infected prisoners in some prisons. Almost half the prisoners from all of the South Australian prisons agreed to participate in our studies, from which we estimate that about 42% of prisoners engage in risk behaviours at least once while incarcerated. Prisoners estimated that 36% of all prisoners inject drugs intravenously at some stage during their stay and that 12% engage in anal intercourse at least once. Interviews with former prisoners who had a history of intravenous drug use revealed that about half had injected themselves while in prison, 60% shared needles and most did not clean shared needles adequately. Most of these prisoners injected themselves once a month or less frequently. The conditions for spread of HIV within the prison system exist but at the current prevalence of infection, transmission can be expected to be infrequent. The opportunity exists now to improve and expand preventive measures.

Entities:  

Mesh:

Year:  1991        PMID: 1892589     DOI: 10.1097/00002030-199107000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.

Authors:  Amir Houshang Mohammad Alizadeh; Seyed Moayed Alavian; Khalil Jafari; Nastaran Yazdi
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

2.  Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran.

Authors:  Saman Zamani; Marziyeh Farnia; Alireza Torknejad; Behrouz Abbasi Alaei; Mehran Gholizadeh; Farzad Kasraee; Masako Ono-Kihara; Koji Oba; Masahiro Kihara
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

3.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.

Authors:  S Allwright; F Bradley; J Long; J Barry; L Thornton; J V Parry
Journal:  BMJ       Date:  2000-07-08

4.  New York inmates' HIV risk behaviors: the implications for prevention policy and programs.

Authors:  N Mahon
Journal:  Am J Public Health       Date:  1996-09       Impact factor: 9.308

5.  Sentinel hospital surveillance of HIV infection in Quebec. Quebec Sentinel Hospital HIV-Seroprevalence Study Group.

Authors:  M Alary; J R Joly; R Parent; M Fauvel; M Dionne
Journal:  CMAJ       Date:  1994-10-01       Impact factor: 8.262

6.  Spread of bloodborne viruses among Australian prison entrants.

Authors:  N Crofts; T Stewart; P Hearne; X Y Ping; A M Breshkin; S A Locarnini
Journal:  BMJ       Date:  1995-02-04

7.  Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users.

Authors:  Mohammad Mehdi Mir-Nasseri; Ashraf Mohammadkhani; Hamid Tavakkoli; Esmaeil Ansari; Hossein Poustchi
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

8.  The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia.

Authors:  Thu Vuong; Nhu Nguyen; Giang Le; Marian Shanahan; Robert Ali; Alison Ritter
Journal:  Harm Reduct J       Date:  2017-01-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.